218 related articles for article (PubMed ID: 30626212)
21. 60 years of Cimicifuga racemosa medicinal products : Clinical research milestones, current study findings and current development.
Henneicke-von Zepelin HH
Wien Med Wochenschr; 2017 May; 167(7-8):147-159. PubMed ID: 28155126
[TBL] [Abstract][Full Text] [Related]
22. [Complementary and alternative therapies for climacteric symptoms].
Reinhard-Hennch B; Strowitzki T; von Hagens C
Gynakol Geburtshilfliche Rundsch; 2006; 46(4):197-213. PubMed ID: 17068404
[TBL] [Abstract][Full Text] [Related]
23. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
Gelenberg AJ; Shelton RC; Crits-Christoph P; Keller MB; Dunner DL; Hirschfeld RM; Thase ME; Russell JM; Lydiard RB; Gallop RJ; Todd L; Hellerstein DJ; Goodnick PJ; Keitner GI; Stahl SM; Halbreich U; Hopkins HS
J Clin Psychiatry; 2004 Aug; 65(8):1114-9. PubMed ID: 15323598
[TBL] [Abstract][Full Text] [Related]
24. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
[TBL] [Abstract][Full Text] [Related]
25. The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa).
Huntley A
Expert Opin Drug Saf; 2004 Nov; 3(6):615-23. PubMed ID: 15500420
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis of human prostate androgen-dependent and -independent carcinoma cells induced by an isopropanolic extract of black cohosh involves degradation of cytokeratin (CK) 18.
Hostanska K; Nisslein T; Freudenstein J; Reichling J; Saller R
Anticancer Res; 2005; 25(1A):139-47. PubMed ID: 15816531
[TBL] [Abstract][Full Text] [Related]
27. Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients.
Walji R; Boon H; Guns E; Oneschuk D; Younus J
Support Care Cancer; 2007 Aug; 15(8):913-21. PubMed ID: 17602247
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of Black cohosh (Actaea/Cimicifuga racemosa) in the treatment of vasomotor symptoms--review of clinical trials].
Kanadys WM; Leszczyńska-Gorzelak B; Oleszczuk J
Ginekol Pol; 2008 Apr; 79(4):287-96. PubMed ID: 18592868
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of an isopropanolic extract of black cohosh on the invasiveness of MDA-mB 231 human breast cancer cells.
Hostanska K; Nisslein T; Freudenstein J; Reichling J; Saller R
In Vivo; 2007; 21(2):349-55. PubMed ID: 17436587
[TBL] [Abstract][Full Text] [Related]
30. Cimicifuga racemosa isopropanolic extract for menopausal symptoms: an observational prospective case-control study.
Guida M; Raffone A; Travaglino A; Neola D; Reppuccia S; Borgo M; Vitale C; Limone A; D'Alessandro P; Massaro G; Mollo A
Gynecol Endocrinol; 2021 Dec; 37(12):1132-1137. PubMed ID: 34477029
[TBL] [Abstract][Full Text] [Related]
31. Effects of an isopropanolic-aqueous black cohosh extract on central body temperature of ovariectomized rats.
Ma X; Zhang H; Wang K; Yang L; Qin L; Bai W; Guan Y; Jia J; Kang J; Zhou C
J Ethnopharmacol; 2011 Oct; 138(1):156-61. PubMed ID: 21924343
[TBL] [Abstract][Full Text] [Related]
32. Drug interactions with St John's wort : mechanisms and clinical implications.
Mannel M
Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
[TBL] [Abstract][Full Text] [Related]
33. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
Markowitz JS; DeVane CL
Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a standardized isopropanolic black cohosh (Actaea racemosa) extract in treatment of uterine fibroids in comparison with tibolone among patients with menopausal symptoms.
Ross SM
Holist Nurs Pract; 2014; 28(6):386-91. PubMed ID: 25314113
[TBL] [Abstract][Full Text] [Related]
35. Effect of St.John's wort (Hypericum perforatum) oily extract for the care and treatment of pressure sores; a case report.
Yücel A; Kan Y; Yesilada E; Akın O
J Ethnopharmacol; 2017 Jan; 196():236-241. PubMed ID: 28011162
[TBL] [Abstract][Full Text] [Related]
36. Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement.
Castelo-Branco C; Navarro C; Beltrán E; Losa F; Camacho M;
Gynecol Endocrinol; 2022 May; 38(5):379-384. PubMed ID: 35403534
[TBL] [Abstract][Full Text] [Related]
37. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.
Gurley BJ; Swain A; Hubbard MA; Williams DK; Barone G; Hartsfield F; Tong Y; Carrier DJ; Cheboyina S; Battu SK
Mol Nutr Food Res; 2008 Jul; 52(7):755-63. PubMed ID: 18214849
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of St John's wort in major depression: a randomized controlled trial.
Shelton RC; Keller MB; Gelenberg A; Dunner DL; Hirschfeld R; Thase ME; Russell J; Lydiard RB; Crits-Cristoph P; Gallop R; Todd L; Hellerstein D; Goodnick P; Keitner G; Stahl SM; Halbreich U
JAMA; 2001 Apr; 285(15):1978-86. PubMed ID: 11308434
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimicifuga racemosa extract in human MCF-7 breast cancer cells.
Hostanska K; Nisslein T; Freudenstein J; Reichling J; Saller R
Biol Pharm Bull; 2004 Dec; 27(12):1970-5. PubMed ID: 15577215
[TBL] [Abstract][Full Text] [Related]
40. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
